References and Notes
1. Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two U.S. surveillance systems. Pediatrics 100(5):831-834 (1997).
2. March of Dimes Metropolitan Atlanta Congenital Defects Program and California Birth Defects Monitoring Program. Leading Categories of Birth Defects. Available: http://www.modimes.org/HealthLibrary2/InfantHealthStatistics/bdtable.htm [cited 27 March 2001].
3. Baskin L, Duckett J. Hypospadias. In: Pediatric Surgery and Urology: Long-Term Outcomes (Stringer M, Oldham K, Howard E, Mouriquand PI, eds). London:WB Saunders, 1998;559-567.
4. Duckett J, Baskin L. Hypospadias. In: Adult and Pediatric Urology (Gillenwater J, Grayhack J, Howards S, Duckett J, eds). St. Louis, MO:Mosby, 1996.
5. Baskin LS, Duckett JW. Buccal mucosa grafts in hypospadias surgery. Br J Urol 76(suppl 3):23-30 (1995).
6. Retik AB, Keating M, Mandell J. Complications of hypospadias repair. Urol Clin North Am 15(2):223-236 (1988).
7. Berg R, Svensson J, Ĺström G. Social and sexual adjustment of men operated for hypospadias during childhood: a controlled study. J Urol 125(3):313-317 (1981).
8. Smith EP, Wacksman J. Evaluation of severe hypospadias. J Pediatr 131(3):344-346 (1997).
9. Jirasek JE, Raboch J, Uher J. The relationship between the development of gonads and external genitals in human fetuses. Am J Obstet Gynecol 101(6):830-833 (1968).
10. Hinman FJ. Penis and male urethra. In: Atlas of Urosurgical Anatomy (Hinman FJ, ed). Philadelphia:WB Saunders, 1993;417-470.
11. Moore KL, Persaud TVN. The Developing Human: Clinically Oriented Embryology. 6th ed. Philadelphia:WB Saunders, 1998.
12. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environ Health Perspect 107:297-302 (1999).
13. Aho M, Koivisto A-M, Tammela TLJ, Auvinen A. Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994. Environ Health Perspect 108:463-465 (2000).
14. Albers N, Ulrichs C, Gliier S, Hiort O, Gernot HG, Sinnecker GHG, Mildenberger H, Brodehl J. Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr 131(3):386-392 (1997).
15. Bentvelsen FM, Brinkmann AO, van der Linden JETM, Schröder FH, Nijman JM. Decreased immunoreactive androgen receptor levels are not the cause of isolated hypospadias. Br J Urol 76(3):384-388 (1995).
16. Aaronson IA, Cakmak MA, Key LL. Defects of the testosterone biosynthetic pathway in boys with hypospadias. J Urol 157(5):1884-1888 (1997).
17. Alléra A, Herbst MA, Griffin JE, Wilson JD, Schweikert H, McPhaul MJ. Mutations of the androgen receptor coding sequence are infrequent in patients with isolated hypospadias. J Clin Endocrinol Metab 80(9):2697-2699 (1995).
18. Sutherland RW, Wiener JS, Hicks JP, Marcelli M, Gonzales ET Jr, Roth DR, Lamb DJ. Androgen receptor gene mutations are rarely associated with isolated penile hypospadias. J Urol 156(2 Pt 2):828-831 (1996).
19. Wilson JD, George FW, Griffin JE. The hormonal control of sexual development. Science 211(4488):1278-1284 (1981).
20. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD. Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 76(1):17-23 (1993).
21. Hiort O, Klauber G, Cendron M, Sinnecker GH, Keim L, Schwinger E, Wolfe HJ, Yandell DW. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 153(5):317-321 (1994).
22. Dollé P, Izpisúa-Belmonte JC, Brown JM, Tickle C, Duboule D. Hox-4 genes and the morphogenesis of mammalian genitalia. Genes Dev 5(10):1767-1776 (1991).
23. Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122(9):2687-2696 (1996).
24. Hsieh-Li HM, Witte DP, Weinstein M, Branford W, Li H, Small K, Potter SS. Hoxa-11 structure, extensive antisense transcription, and function in male and female fertility. Development 121(5):1373-1385 (1995).
25. Podlasek CA, Duboule D, Bushman W. Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13. Dev Dyn 208(4):454-465 (1997).
26. Mortlock DP, Innis JW. Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 15(2):179-180 (1997).
27. Donnenfeld AE, Schrager DS, Corson SL. Update on a family with hand-foot-genital syndrome: hypospadias and urinary tract abnormalities in two boys from the fourth generation. Am J Med Gen 44(4):482-484 (1992).
28. Fryns JP, Vogels A, Decock P, Van den Berghe H. The hand-foot-genital syndrome: on the variable expression in affected males. Clin Genet 43(5):232-234 (1993).
29. Haraguchi R, Suzuki K, Murakami R, Sakai M, Kamikawa M, Kengaku M, Sekine K, Kawano H, Kato S, Ueno N, et al. Molecular analysis of external genitalia formation: the role of fibroblast growth factor (Fgf) genes during genital tubercle formation. Development 127(11):2471-2479 (2000).
30. Kurzrock EA, Baskin LS, Li Y, Cunha GR. Epithelial-mesenchymal interactions in development of the mouse fetal genital tubercle. Cells Tissues Organs 164(3):125-130 (1999).
31. Podlasek CA, Barnett DH, Clemens JQ, Bak PM, Bushman W. Prostate development requires Sonic hedgehog expressed by the urogenital sinus epithelium. Dev Biol 209(1):28-39 (1999).
32. Cohn MJ, Bright PE. Molecular control of vertebrate limb development, evolution and congenital malformations. Cell Tissue Res 296(1):3-17 (1999).
33. Gearhart JP, Linhard HR, Berkovitz GD, Jeffs RD, Brown TR. Androgen receptor levels and 5 alpha-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias. J Urol 140(5 Pt 2):1243-1246 (1988).
34. Bentvelsen FM, McPhaul MJ, Wilson JD, George FW. The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen. Mol Cell Endocrinol 105(1):21-26 (1994).
35. Harris E. Genetic epidemiology of hypospadias. Epidemiol Rev 12:29-40 (1990).
36. Fisch H, Golden RJ, Libersen GL, Hyun GS, Madsen P, New MI, Hensle TW. Maternal age as a risk factor for hypospadias. J Urol 165(3):934-936 (2001).
37. Sweet RA, Schrott HG, Kurland R, Culp OS. Study of the incidence of hypospadias in Rochester, Minnesota, 1940-1970, and a case-control comparison of possible etiologic factors. Mayo Clin Proc 49(1):52-58 (1974).
38. Fritz G, Czeizel AE. Abnormal sperm morphology and function in the fathers of hypospadiacs. J Reprod Fertil 106(1):63-66 (1996).
39. Fredell L, Lichtenstein P, Pedersen NL, Svensson J, Nordenskjold A. Hypospadias is related to birth weight in discordant monozygotic twins. J Urol 160(6 Pt 1):2197-2199 (1998).
40. Stoll C, Alembik Y, Roth MP, Dott B. Genetic and environmental factors in hypospadias. J Med Genet 27(9):559-563 (1990).
41. de Zegher F, Francois I, Boehmer AL, Saggese G, Muller J, Hiort O, Sultan C, Clayton P, Brauner R, Cacciari E, et al. Androgens and fetal growth. Horm Res 50(4):243-244 (1998).
42. Aarskog D. Maternal progestins as a possible cause of hypospadias. N Engl J Med 300(2):75-78 (1979).
43. Macnab AJ, Zouves C. Hypospadias after assisted reproduction incorporating in vitro fertilization and gamete intrafallopian transfer. Fertil Steril 56(5):918-922 (1991).
44. Silver RI, Rodriguez R, Chang TS, Gearhart JP. In vitro fertilization is associated with an increased risk of hypospadias. J Urol 161(6):1954-1957 (1999).
45. Kallen B, Mastroiacovo P, Lancaster PAL, Mutchinick O, Kringelbach M, Martinez-Frias ML, Robert E, Castilla EE. Oral contraceptives in the etiology of isolated hypospadias. Contraception 44(2):173-182 (1991).
46. Raman-Wilms L, Tseng LA, Wighardt S, Einarson TR, Koren G. Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis. Obstet Gynecol 85(1):141-149 (1995).
47. Cosgrove MD, Benton B, Henderson BE. Male genitourinary abnormalities and maternal diethylstilbestrol. J Urol 117(2):220-222 (1977).
48. Gill WB, Schumacher GF, Bibbo M, Straus FH, Schoenberg HW. Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J Urol 122(1):36-39 (1979).
49. North K, Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int 85(1):107-113 (2000).
50. Brock JW, Melnyk LJ, Caudill SP, Needham LL, Bond AE. Serum levels of several organochlorine pesticides in farmers correspond with dietary exposure and local use history. Toxicol Ind Health 14(1-2):275-289 (1998).
51. Sonawane BR. Chemical contaminants in human milk: an overview. Environ Health Perspect 103(suppl 6):197-205 (1995).
52. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, Jégou B, Jensen TK, Jouannet P, Keiding N, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104(suppl 4):741-803 (1996).
53. Sharpe RM, Skakkebćk NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341(8857):1392-1395 (1993).
54. Bergström R, Adami HO, Mohner M, Zatonski W, Storm H, Ekbom A, Tretli S, Teppo L, Akre O, Hakulinen T. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 88(11):727-733 (1996).
55. Carlsen E, Giwercman A, Keiding N, Skakkebćk NE. Declining semen quality and increasing incidence of testicular cancer: is there a common cause? Environ Health Perspect 103(suppl 7):137-139 (1995).
56. Cheng W, Mya GH, Saing H. Associated anomalies in patients with undescended testes. J Trop Pediatr 42(4):204-206 (1996).
57. Prener A, Engholm G, Jensen OM. Genital anomalies and risk for testicular cancer in Danish men. Epidemiology 7(1):14-19 (1996).
58. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p´-DDE is a potent androgen receptor antagonist. Nature 375(6532):581-585 (1995).
59. Kelce WR, Wilson EM. Environmental antiandrogens: developmental effects, molecular mechanisms, and clinical implications. J Mol Med 75(3):198-207 (1997).
60. Foster W, Chan S, Platt L, Hughes C. Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J Clin Endocrinol Metab 85(8):2954-2957 (2000).
61. Curley A, Copeland MF, Kimbrough RD. Chlorinated hydrocarbon insecticides in organs of stillborn and blood of newborn babies. Arch Environ Health 19(5):628-632 (1969).
62. Prahalada S, Tarantal AF, Harris GS, Ellsworth KP, Clarke AP, Skiles GL, MacKenzie KI, Kruk LF, Ablin DS, Cukierski MA, et al. Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta). Teratology 55(2):119-131 (1997).
63. Gupta C, Chandorkar A, Nguyen AP. Activation of androgen receptor in epidermal growth factor modulation of fetal mouse sexual differentiation. Mol Cell Endocrinol 123(1):89-95 (1996).
64. Gupta C, Siegel S, Ellis D. The role of EGF in testosterone-induced reproductive tract differentiation. Dev Biol 146(1):106-116 (1991).
65. Nelson KG, Takahashi T, Bossert NL, Walmer DK, McLachlan JA. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc Natl Acad Sci USA 88(1):21-25 (1991).
66. El-Galley RES, Smith E, Cohen C, Petros JA, Woodard J, Galloway NTM. Epidermal growth factor (EGF) and EGF receptor in hypospadias. Br J Urol 79(1):116-119 (1997).
67. El-Sabeawy F, Wang S, Overstreet J, Miller M, Lasley B, Enan E. Treatment of rats during pubertal development with 2,3,7,8-tetrachlorodibenzo-p-dioxin alters both signaling kinase activities and epidermal growth factor receptor binding in the testis and the motility and acrosomal reaction of sperm. Toxicol Appl Pharmacol 150(2):427-442 (1998).
68. Sanderson JT, Janz DM, Bellward GD, Giesy JP. Effects of embryonic and adult exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin on hepatic microsomal testosterone hydroxylase activities in great blue herons (Ardea herodias). Environ Toxicol Chem 16(6):1304-1310 (1997).
69. Haake J, Kelley M, Keys B, Safe S. The effects of organochlorine pesticides as inducers of testosterone and benzo[a]pyrene hydroxylases. Gen Pharmacol 18(2):165-169 (1987).
70. Paolini M, Pozzetti L, Mesirca R, Sapone A, Cantelli-Forti G. Testosterone hydroxylase in evaluating induction and suppression of murine CYP isoenzymes by fenarimol. Arch Toxicol 70(7):451-456 (1996).
71. Gray LE Jr, Wolf C, Lambright C, Mann P, Price M, Cooper RL, Ostby J. Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p´-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicol Ind Health 15(1-2):94-118 (1999).
72. Hurst CH, DeVito MJ, Setzer RW, Birnbaum LS. Acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in pregnant Long Evans rats: association of measured tissue concentrations with developmental effects. Toxicol Sci 53(2):411-420 (2000).
73. Gray LE Jr, Ostby J, Monosson E, Kelce WR. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol Ind Health 15(1-2):48-64 (1999).
74. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE Jr. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126(2):276-285 (1994).
75. Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE Jr. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. Toxicol Ind Health 15(1-2):80-93 (1999).
76. Gray LE Jr. Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol Lett 102-103:331-335 (1998).
77. Gray LE Jr, Price M, Lambright C, Wolf C, Hotchkiss A, Parks L, Ostby J. Environmental antiandrogens:
the malformation pattern varies with the mechanism of antiandrogenic action [Abstract]. Biol Reprod 60(suppl 1):201 (1999).
78. Parks LG, Ostby JS, Lambright CR, Abbott BD, Gray LE Jr. Perinatal butyl benzyl phthalate (BBP) and bis(2-ethylhexyl)phthalate (DEHP) exposures induce antiandrogenic effects in Sprague-Dawley (SD) rats [Abstract]. Biol Reprod 60(suppl 1):153 (1999).
79. McLachlan JA. Rodent models for perinatal exposure to diethylstilbestrol and their relation to human disease in the male. In: Developmental Effects of Diethylstilbestrol (DES) in Pregnancy (Herbst AL, Bern HA, eds). New York:Thieme-Stratton, 1981;148-157.
80. Henderson BE, Benton B, Cosgrove M, Baptista J, Aldrich J, Townsend D, Hart W, Mack TM. Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics 58(4):505-507 (1976).
81. Vorherr H, Messer RH, Vorherr UF, Jordan SW, Kornfeld M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem Pharmacol 28(12):1865-1877 (1979).
82. Gray LE Jr, Ostby J, Cooper RL, Kelce WR. The estrogenic and antiandrogenic pesticide methoxychlor alters the reproductive tract and behavior without affecting pituitary size or LH and prolactin secretion in male rats. Toxicol Ind Health 15(1-2):37-47 (1999).
83. Ma L, Benson GV, Lim H, Dey SK, Maas RL. Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in Müllerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 197(2):141-154 (1998).
84. Santti R, Makela S, Strauss, L, Korkman J, Kostian M-J. Phytoestrogens: potential endocrine disruptors in males. In: Environmental Endocrine-Disrupting Chemicals: Neural, Endocrine, and Behavioral Effects (Colborn T, vom Saal F, Short P, eds). Princeton, NJ:Princeton Scientific Publishing, 1998;263-280.
85. Bern H, Blair P, Brasseur S, Colborn T, Cunha GR, Davis W, Dohler KD, Fox G, Fry M, Gray E, et al. Statement from the work session on chemically-induced alterations in sexual development: the wildlife/human connection. In: Chemically Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection (Colborn T, Clement C, eds). Princeton, NJ:Princeton Scientific, 1992.
86. Schettler T, Solomon GM, Valenti M, Huddle A, eds. Generations at Risk: Reproductive Health and the Environment. Cambridge, MA:MIT Press, 1999.
87. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, Lucier GW, Jackson RJ, Brock JW. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect 108:979-982 (2000).
88. Voldner EC, Li Y-F. Global usage of selected persistent organochlorines. Sci Total Environ 160-161:201-210 (1995).
89. Raloff J. New concerns about phthalates: ingredients of common plastics may harm boys as they develop. Sci News 158(10):152 (2000).
90. Garry VF, Schreinemachers D, Harkins ME, Griffith J. Pesticide appliers, biocides, and birth defects in rural Minnesota. Environ Health Perspect 104:394-399 (1996).
91. Thériault G, Iturra H, Gingras S. Evaluation of the association between birth defects and exposure to ambient vinyl chloride. Teratology 27(3):359-370 (1983).
92. Mastroiacovo P, Spagnolo A, Marni E, Meazza L, Bertollini R, Segni G. Birth defects in the Seveso area after TCDD contamination. JAMA 259(11):1668-1672 (1988).
93. Dolk H, Vrijheid M, Armstrong B, Abramsky L, Bianchi F, Garne E, Nelen V, Robert E, Scott JES, Stone D, et al. Risk of congenital anomalies near hazardous-waste landfill sites in Europe: the EUROHAZCON study. Lancet 352(9126):423-427 (1998).
94. Weidner IS, Mřller H, Jensen TK, Skakkebćk NE. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 106:793-796 (1998).
95. Kristensen P, Irgens LM, Andersen A, Bye AS, Sundheim L. Birth defects among offspring of Norwegian farmers, 1967-1991. Epidemiology 8(5):537-544 (1997).
96. Hayes HM Jr, Wilson GP. Hospital incidence of hypospadias in dogs in North America. Vet Rec 118(22):605-607 (1986).
97. Stamper MA, Norton T, Spodnick G, Marti J, Loomis M. Hypospadias in a polar bear (Ursinus maritimus). J Zoo Wildl Med 30(1):141-144 (1999).
98. Henny CJ, Grove RA, Hedstrom OR. A Field Evaluation of Mink and River Otter on the Lower Columbia River and the Influence of Environmental Contaminants. Final Report. Submitted to the Lower Columbia River Bi-State Water Quality Program. Contract Nos. ODEQ 143-94 and WDE C9500038. Corvallis OR: Nationbal Biological Service, Forest and Rangeland Ecosystem Science Center, Northwest Research Station, 1996.
99. Cattet M. Abnormal sexual differentiation in black bears (Ursus americanus) and brown bears (Ursus arctos). J Mammal 69(4):849-852 (1988).
100. Wiig O, Derocher AE, Cronin MM, Skaare JU. Female pseudohermaphrodite polar bears at Svalbard. J Wildl Dis 34(4):792-796 (1998).
101. Guillette LJ Jr, Brock JW, Rooney AA, Woodward AR. Serum concentrations of various environmental contaminants and their relationship to sex steroid concentrations and phallus size in juvenile American alligators. Arch Environ Contam Toxicol 36(4):447-455 (1999).
102. Guillette LJ Jr, Orlando EF, Milnes MM, Gunderson MP, Edwards TM, Crain DA, Binczik G, Bermudez DS, Bryan TA. Endocrine disrupting contaminants: lessons from wildlife. In: The International Symposium on Environmental Endocrine Disrupters, 16-18 December 2000, Pacifico Yokohama, Kanagawa, Japan. Tokyo:Environment Agency, Government of Japan, 2000;47.
103. Warner MR, Warner RL, Clinton CW. Reproductive tract calculi, their induction, age incidence, composition, and biological effects in Balb/c Crgl mice injected as newborns with estradiol-17ß. Biol Reprod 20(2):310-322 (1979).
104. Baskin L. Unpublished data.
105. Laden F, Neas LM, Spiegelman D, Hankinson SE, Willett WC, Ireland K, Wolff MS, Hunter DJ. Predictors of plasma concentrations of DDE and PCBs in a group of U.S. women. Environ Health Perspect 107:75-81 (1999).
Last Updated: November 7, 2001